Drug Shortage Report for SANDOZ OLOPATADINE
Report ID | 89412 |
Drug Identification Number | 02358913 |
Brand name | SANDOZ OLOPATADINE |
Common or Proper name | OLOPATADINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | OLOPATADINE |
Strength(s) | 0.1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5ml |
ATC code | S01GX |
ATC description | DECONGESTANTS AND ANTIALLERGICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2019-06-24 |
Estimated end date | 2019-08-26 |
Actual end date | 2019-09-06 |
Shortage status | Resolved |
Updated date | 2019-09-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-09-10 | French | Compare |
v7 | 2019-09-10 | English | Compare |
v6 | 2019-08-14 | French | Compare |
v5 | 2019-08-14 | English | Compare |
v4 | 2019-07-24 | French | Compare |
v3 | 2019-07-24 | English | Compare |
v2 | 2019-07-16 | French | Compare |
v1 | 2019-07-16 | English | Compare |
Showing 1 to 8 of 8